X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
schizophrenia (565) 565
psychiatry (390) 390
humans (364) 364
index medicus (354) 354
schizophrenia - drug therapy (280) 280
antipsychotic agents - administration & dosage (253) 253
male (245) 245
female (235) 235
adult (234) 234
pharmacology & pharmacy (224) 224
risperidone (208) 208
antipsychotic agents - therapeutic use (191) 191
middle aged (189) 189
double-blind (166) 166
efficacy (158) 158
paliperidone palmitate (153) 153
safety (151) 151
delayed-action preparations (141) 141
antipsychotic agents - adverse effects (135) 135
antipsychotics (128) 128
relapse (125) 125
long-acting injectable (124) 124
adherence (121) 121
clinical neurology (120) 120
psychotropic drugs (118) 118
treatment outcome (117) 117
risperidone - administration & dosage (116) 116
antipsychotic drugs (112) 112
injections, intramuscular (110) 110
injections (98) 98
drug therapy (91) 91
schizoaffective disorder (89) 89
long-acting injection (88) 88
risperidone - therapeutic use (87) 87
antipsychotic (86) 86
neurosciences (85) 85
maintenance treatment (82) 82
administration, oral (78) 78
depot (78) 78
long-acting injectable antipsychotics (78) 78
aged (77) 77
medication (77) 77
adolescent (76) 76
atypical antipsychotics (76) 76
injectable risperidone (76) 76
open-label (75) 75
original research (74) 74
young adult (72) 72
long-acting risperidone (70) 70
psychotic disorders - drug therapy (70) 70
oral antipsychotics (69) 69
psychosis (68) 68
olanzapine (67) 67
risperidone - adverse effects (66) 66
hospitalization (65) 65
pharmacokinetics (65) 65
aripiprazole (64) 64
mental disorders (64) 64
patients (64) 64
drug administration schedule (63) 63
medication adherence (63) 63
psychiatric status rating scales (63) 63
delayed-action preparations - administration & dosage (62) 62
tolerability (59) 59
patient compliance (58) 58
delayed-action preparations - therapeutic use (57) 57
care and treatment (56) 56
bipolar disorder (55) 55
drugs (55) 55
1st-episode schizophrenia (54) 54
analysis (54) 54
depot antipsychotics (53) 53
injection (52) 52
nonadherence (50) 50
schizophrenic psychology (50) 50
studies (47) 47
medicine, general & internal (46) 46
time factors (45) 45
quality of life (44) 44
haloperidol (43) 43
research (43) 43
retrospective studies (43) 43
double-blind method (42) 42
long-acting (41) 41
neuroleptics (41) 41
1st episode (40) 40
dose-response relationship, drug (39) 39
attitudes (38) 38
neuropsychiatric disease and treatment (38) 38
prevention (38) 38
quality-of-life (38) 38
antipsychotic agents - economics (37) 37
metaanalysis (37) 37
trial (37) 37
paliperidone palmitate - therapeutic use (36) 36
dosage and administration (35) 35
medical research (35) 35
prospective studies (35) 35
antipsychotic agents - pharmacology (34) 34
medicine, experimental (34) 34
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (671) 671
French (27) 27
Japanese (4) 4
Spanish (4) 4
German (3) 3
Italian (2) 2
Polish (2) 2
Czech (1) 1
Dutch (1) 1
Portuguese (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nordic Journal of Psychiatry, ISSN 0803-9488, 09/2018, Volume 72, Issue 1, pp. S36 - S39
Journal Article
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, ISSN 0271-0749, 11/2019, Volume 39, Issue 6, pp. 611 - 619
Purpose/Background Despite proven benefits of long-acting injectables (LAIs), these are frequently underused by the psychiatrists. Accordingly, this study... 
PSYCHIATRY | MEDICATION NONADHERENCE | EAST-ASIA | long-acting injectables | ORAL ATYPICAL ANTIPSYCHOTICS | 1ST-EPISODE SCHIZOPHRENIA | ATTITUDES | ADHERENCE | COMMUNITY TREATMENT ORDERS | perceptions | psychiatrists | PRESCRIPTION | PHARMACOLOGY & PHARMACY | DEPOT ANTIPSYCHOTICS | INJECTIONS
Journal Article
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, ISSN 0271-0749, 09/2019, Volume 39, Issue 5, pp. 441 - 445
Journal Article
Journal Article
International Clinical Psychopharmacology, ISSN 0268-1315, 03/2019, Volume 34, Issue 2, pp. 51 - 56
Long-acting injectable (LAI) antipsychotics could be a favorable option of treatment and have some advantages over oral medications. The aim of this study was... 
1ST EPISODE | MEDICATION | adherence to treatment | PSYCHIATRY WFSBP GUIDELINES | depot | PSYCHIATRY | first-episode psychosis | risperidone | SCHIZOPHRENIA | BIOLOGICAL TREATMENT | RELAPSE | UPDATE 2012 | TREATMENT RESPONSE | long-acting injectable antipsychotics | PHARMACOLOGY & PHARMACY | WORLD FEDERATION | Usage | Care and treatment | Antipsychotic drugs | Psychoses
Journal Article
Journal Article
by Lin, CH and Chen, FC and Chan, HY and Hsu, CC
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, ISSN 1461-1457, 09/2019, Volume 22, Issue 9, pp. 541 - 547
Background: This study aimed to investigate and compare time to rehospitalization in patients with schizophrenia receiving long-acting injectable... 
MEDICATION | oral antipsychotics | PSYCHIATRY | rehospitalization | RISPERIDONE | schizophrenia | NEUROSCIENCES | ADHERENCE | CARE | CLINICAL NEUROLOGY | second-generation antipsychotics | COMMUNITY TREATMENT ORDERS | NATIONWIDE | long-acting injectable antipsychotics | PHARMACOLOGY & PHARMACY | OLANZAPINE
Journal Article
Journal Article